"Lung Cancer: We’re Listening"

A survey by Boehringer Ingelheim to share and compare experiences of lung cancer patients and family members worldwide

Lung Cancer: We're Listening is a survey that uses pictures to allow lung cancer patients and family members from around the world to express, share and compare experiences. The information gathered from this survey will be used to improve lung cancer awareness and support services by Boehringer Ingelheim.

If you have lung cancer, or care for a loved one with lung cancer, please click on the link below to complete this short survey and to tell them about some of the challenges you may be facing right now– it only takes a few minutes.

Go to http://www.wearelistening.info to share your experience of life with lung cancer.

For more information, read the official Launch Press Release.

Tags Lung cancer Boehringer Ingelheim

Last update

Tuesday 28 February 2023

Related content

In the medical laboratory, the patient undergoes an MRI or CT scan under the supervision of a radiologist, in the control room, the doctor observes the procedure and monitors the scan results.

Reflecting on World Cancer Day, Israel Lowy, MD, PhD, Senior Vice President, Clinical Development Unit Head, Oncology at Regeneron, a UICC partner, shares his view on the future of personalised medicine in lung cancer and the importance of people-centred care.

In an interview with UICC marking Lung Cancer Awareness Month, Swasti Mishra of Lung Cancer Europe, a UICC member, explains how improving early detection, evidence-based testing, and psychosocial care can help overcome disparities and improve outcomes in lung cancer.